Cargando…

Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis

BACKGROUND: RPLP2, an integral part of ribosomal stalk, plays an important role in the tumorigenesis of various cancers. However, its specific effect on HCC remains elusive. METHODS: TCGA, GTEx, HCCDB, HPA, UALCAN, MethSurv, TISIDB, K–M plotter, FerrDb, RNAactDrug, STRING, Cytoscape and R studio wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jiaxing, Huang, Meiyuan, Deng, Shuang, Wang, Haiyan, Wang, Zuli, Yan, Bokang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656893/ https://www.ncbi.nlm.nih.gov/pubmed/37980521 http://dx.doi.org/10.1186/s12935-023-03140-0

Ejemplares similares

The ubiquitin‐specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression
por: Yan, Bokang, et al.
Publicado: (2023)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Ribosomal stalk proteins RPLP1 and RPLP2 promote biogenesis of flaviviral and cellular multi-pass transmembrane proteins
por: Campos, Rafael K, et al.
Publicado: (2020)

A pan-cancer analysis of the role of USP5 in human cancers
por: Yan, Bokang, et al.
Publicado: (2023)

RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells
por: Xie, Changji, et al.
Publicado: (2021)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus
por: Dong, Hui-Jun, et al.
Publicado: (2023)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

RPLP1, a Crucial Ribosomal Protein for Embryonic Development of the Nervous System
por: Perucho, Laura, et al.
Publicado: (2014)

RPLP1, an NS4B-interacting protein, enhances production of CSFV through promoting translation of viral genome
por: Zhang, Longxiang, et al.
Publicado: (2022)

Downregulation of lncRNA RPLP0P2 inhibits cell proliferation, invasion and migration, and promotes apoptosis in colorectal cancer
por: Yuan, Hang, et al.
Publicado: (2021)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
por: Zhang, Deguo, et al.
Publicado: (2023)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis
por: Tang, Jianing, et al.
Publicado: (2023)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2012)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis
por: Zhang, Yixi, et al.
Publicado: (2020)

Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer
por: Huang, Naiqi, et al.
Publicado: (2019)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis
por: Jin, An‐Li, et al.
Publicado: (2022)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Shu, Bo, et al.
Publicado: (2018)

CNN3 acts as a potential oncogene in cervical cancer by affecting RPLP1 mRNA expression
por: Xia, Lili, et al.
Publicado: (2020)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Li, Dezhi, et al.
Publicado: (2020)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
por: Li, Chongyi, et al.
Publicado: (2015)

Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer
por: Xu, Xin, et al.
Publicado: (2022)

HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma
por: Wang, Wei-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dviilob7vhf59i6ei3lo33oig0